Sitemap - 2025 - Signals From [Space]

The Current Landscape of Value-Based Kidney Care, Part 2

What Counts as a Timely Referral for Kidney Transplant?

Finding My Voice in the New York Times

Potential Energy: IgAN Milestone, 70k-Patient SGLT2 Data, Creating AI Guardrails, Transplant Trials RFI & Reintroducing KCAPA

How do we increase living kidney donation?

The Current Landscape of Value-Based Kidney Care, Part 1

How should we deliver kidney care in rural America?

Aligning Kidney Policy with Patient Needs: A Conversation with Miriam Godwin and Kevin Fowler

How To Advance Kidney Health Through Genetic Discovery

Predicting Kidney Disease Progression with Biomarkers, Clinical Values, and AI/ML

Testing Our Limits: AI CKD Screening, Portable PD, VBC Slows eGFR Decline, Immune System Wins Nobel, CRISPR-GPT & More

The State of AI in Kidney Care

Mapping the Xeno Immune Response With PITOR's Erwan Morgand and Alessia Giarraputo

Brief: Four Signals from DHNY 2025

Too Grateful To Complain?

How UCSD is Addressing the Public Health Crisis in Organ Transplantation

Funding Frontiers: $50B for Rural Health, $1.5B for OrganOx, Strive’s $550M, Maze gets $150M, & More

How Genetic Testing Is Transforming CKD Diagnosis and Rare Disease Drug Trials

Signals Turns Two: Thank You

Inside ChenMed’s Kidney Care Model

Life on Immunosuppression: What 10,000 Transplant Recipients Just Taught Us

How To Build A New Kidney Care Model From The Ground Up

Turning Points: FDA C3G Approval, AST Surveys 10K Recipients, Frenova's New JV, and the 2026 ESRD PPS

Michelle Yeboah on Taking Back Her Life After Lupus, Dialysis, and Transplant

25 Questions for Kidney Transplant

How Genetic Testing Is Powering Kidney Trials from Start to Finish

Designing Kidney Care Navigation Within a Health System

So, you want to change the world.

Kidney Capital, Part 3: Top Underfunded Opportunities in Kidney Care

Jacob Upperco on Creating Novel Devices and Delivering Insight and Treatment Inside the Kidney: Signals KOLs

Tipping Points: Golden Era for CKD Drugs, Trillion Dollar Medicaid Cuts, New Codes for AMKD, & More

We Are Here: Five Charts That Explain the Current State of Kidney Care

Winner Take All: Does Transitional Care Billing Undermine Team-Based Kidney Care?

Signals Brief: Should Primary Care Drive CKD Screening?

From Promise to Proof: AI-Designed Drugs Deliver, Xeno Workshop at MGH, Climate-Driven CKD Risks, & More

Signals Brief: Spend Now to Save Later? What We Know About The KCC Model’s Cost Curve and Future Direction

Signals Recap: A Week of Firsts — Kidney Disease Goes Global, Personalized CRISPR, MAHA's Report, CMS Targets MA, & more

Eugene Lin on how regulatory failures have crippled dialysis care: Signals KOLs

Signals Recap: Health Policy Shakeup—Medicaid Cuts, Drug Pricing Reform, FDA AI Strategy & CMMI's New Path

Wanted: Kidney Care Navigators

Signals Recap: Prioritizing Kidney Health on the World Stage and Here at Home

Signals Brief: What a Proposed $40B Cut to HHS Means for Kidney Care

Signals Recap: System Under Review—HHS, CMS & OPTN in Transition, Avalere's Latest CMMI Analysis, & More...

A Better Way to Find the Right People and Opportunities in Kidney Health

Update: Dialysis Decade: How New Devices Get To Market

Ben Hippen on IOTA, incentives, and how to build a transplant-inclusive kidney care model: Signals KOLs

Signals Recap: CMS Ends ETC, MedPAC Report, World Kidney Day, & More…

Signals Brief: CMS Shuts Down ETC—What's Next for Kidney Payments?

John Erbey on Targeting the Kidney’s Collecting System to Improve Fluid Removal & Sustain Function: Signals KOLs

John Erbey on the $650 billion kidney crisis and the problem no one seems to talking about: Signals KOLs

Signals Recap: Mass Layoffs at HHS & VA; NYT Investigates Transplant Chaos; FDA Fast-Tracks Kidney Cancer Drug & More…

Signals Brief: DaVita Earnings in Q4 2024

Signals Recap: Humana-Monogram, FDA Approves Xeno Trials, Travere Targets FSGS, National Donor Day, & More...

KCC in Numbers: What We Know, What We Don't, and What Comes Next

Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More...

Welcome to the Kidneyverse

Update: We should probably talk about barriers to home dialysis

Signals Recap: Azar on VBC, Carilion-UVa, TransMedics, JPM Takeaways, Ozempic, Vafseo, & More...

The State & Future of Nutrition in Kidney Health: Expert Q&A

Osman Khawar (Diality) on Moda-Flx and the need for more flexible dialysis treatment options: Signals KOLs

Signals Data Room: Key Metrics, Insights, & Analysis on Dialysis, Transplant, VBC, Devices, Diagnostics, Drugs & More

20 Things We Should Redesign in 2025 for a Healthier, More Secure World

Introducing: Transplant Databases